Shinshu University, abbreviated to Shindai, is a Japanese national university located in Matsumoto, Nagano Prefecture, Japan. As the only university in Japan bearing the name of a former Japanese province, it bears the name "Shinshu", and is firmly rooted in the many regions of Nagano Prefecture.

During the past decade, Yukio Nakamura conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yukio Nakamura" #1 collaborator was "Showa Inan General Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Yukio Nakamura" are "Osteoporosis" (7 trials), "Rheumatoid Arthritis" (3 trials), "Gastrointestinal Erosions and/or Ulcers" (1 trials), "Hip OA" (1 trials) and "Osteoarthritis of Multiple Joints" (1 trials). Many other conditions were trialed in "Yukio Nakamura" in a lesser frequency.

Most popular intervention types in "Yukio Nakamura" are "Drug" (10 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by ""Baricitinib", "olumiant®"" (1 trials), ""Biologics"" (1 trials), ""Teriparatide", "Forteo® or Teribon"" (1 trials), ""Zoledronic acid", "Reclast®"" (1 trials) and ""Zoledronic acid", "Reclast®" and "active vitamin D", "alfacalcidol®"" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yukio Nakamura" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Yukio Nakamura". undefined are not yet recruiting, 11 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yukio Nakamura, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yukio Nakamura, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".